NO20000062L - Prostaglandin derivatives free of side effects for the treatment of glaucoma - Google Patents

Prostaglandin derivatives free of side effects for the treatment of glaucoma

Info

Publication number
NO20000062L
NO20000062L NO20000062A NO20000062A NO20000062L NO 20000062 L NO20000062 L NO 20000062L NO 20000062 A NO20000062 A NO 20000062A NO 20000062 A NO20000062 A NO 20000062A NO 20000062 L NO20000062 L NO 20000062L
Authority
NO
Norway
Prior art keywords
glaucoma
treatment
side effects
prostaglandin derivatives
derivatives free
Prior art date
Application number
NO20000062A
Other languages
Norwegian (no)
Other versions
NO20000062D0 (en
Inventor
Johan W Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000062(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000062L publication Critical patent/NO20000062L/en
Publication of NO20000062D0 publication Critical patent/NO20000062D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
NO20000062A 1997-07-11 2000-01-06 Prostaglandin derivatives free of side effects for the treatment of glaucoma NO20000062D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (en) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (2)

Publication Number Publication Date
NO20000062L true NO20000062L (en) 2000-01-06
NO20000062D0 NO20000062D0 (en) 2000-01-06

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000062A NO20000062D0 (en) 1997-07-11 2000-01-06 Prostaglandin derivatives free of side effects for the treatment of glaucoma

Country Status (19)

Country Link
EP (1) EP1014991A1 (en)
JP (1) JP2002509543A (en)
KR (1) KR20010021682A (en)
CN (1) CN1169528C (en)
AU (1) AU739828B2 (en)
BR (1) BR9815501A (en)
CA (1) CA2294779A1 (en)
HK (1) HK1029942A1 (en)
HU (1) HUP0003106A3 (en)
IL (1) IL133871A (en)
IS (1) IS5333A (en)
NO (1) NO20000062D0 (en)
NZ (1) NZ501834A (en)
PL (1) PL337940A1 (en)
RU (1) RU2207858C2 (en)
SE (1) SE9702706D0 (en)
SK (1) SK183499A3 (en)
TR (1) TR200000008T2 (en)
WO (1) WO1999002165A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (en) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
WO2004031142A2 (en) * 2002-09-16 2004-04-15 Texas Tech University System Inhibition of metallo-beta-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (en) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Method for obtaining the derivatives of 13,14-dihydro-PGF₂α
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US20110038884A1 (en) 2008-04-28 2011-02-17 National University Co., Hamamatsu Univer. School Of Medicine Immunopotentiating agent comprising ep1 agonist
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (en) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
CA2777290C (en) 2009-10-16 2016-06-28 Cayman Chemical Company, Incorporated Process for the preparation of f-series prostaglandins
EA027416B1 (en) 2012-03-28 2017-07-31 Мерк Патент Гмбх Bicyclic pyrazinone derivatives
JP2012246301A (en) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Method for preparing prostaglandins f
EP3811943B1 (en) 2013-03-15 2023-02-22 Aerie Pharmaceuticals, Inc. Compound for use in the treatment of ocular disorders
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US11389441B2 (en) 2016-08-31 2022-07-19 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
MX2019011784A (en) 2017-03-31 2019-11-18 Aerie Pharmaceuticals Inc Aryl cyclopropyl-amino-isoquinolinyl amide compounds.
EP3849555A4 (en) 2018-09-14 2022-05-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
EP0664707B1 (en) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma

Also Published As

Publication number Publication date
JP2002509543A (en) 2002-03-26
KR20010021682A (en) 2001-03-15
SK183499A3 (en) 2000-07-11
HUP0003106A2 (en) 2001-01-29
PL337940A1 (en) 2000-09-11
CA2294779A1 (en) 1999-01-21
CN1262623A (en) 2000-08-09
CN1169528C (en) 2004-10-06
RU2207858C2 (en) 2003-07-10
HK1029942A1 (en) 2001-04-20
IS5333A (en) 2000-01-07
IL133871A0 (en) 2001-04-30
AU8368398A (en) 1999-02-08
WO1999002165A1 (en) 1999-01-21
EP1014991A1 (en) 2000-07-05
BR9815501A (en) 2001-07-17
TR200000008T2 (en) 2000-05-22
SE9702706D0 (en) 1997-07-11
NZ501834A (en) 2002-05-31
AU739828B2 (en) 2001-10-18
IL133871A (en) 2004-09-27
HUP0003106A3 (en) 2002-12-28
NO20000062D0 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
NO20000062L (en) Prostaglandin derivatives free of side effects for the treatment of glaucoma
EE04190B1 (en) Use of substituted benzopyran derivatives for the treatment of inflammation
DE69613368D1 (en) CHINAZOLIN DERIVATIVES
DE69613369D1 (en) CHINAZOLIN DERIVATIVES
DE69613367T2 (en) CHINAZOLIN DERIVATIVES
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20001962D0 (en) Therapeutic use of quinoline derivatives
NO20002443D0 (en) Process for the preparation of derivatives of the taxoid class
NO914667D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLED DERIVATIVES
BR9507179A (en) Derivatives of 3-aryl-4-hydroxy-delta3-dihydrothiophene
NO910395L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 4-ISOXAZOLCARBOXAMIDE DERIVATIVES.
NO953367D0 (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as drugs
NO912797D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE CARBOSTIRIL DERIVATIVES.
NO991734D0 (en) Pyrazolinones for the treatment of potency disorders
NO905327L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBAMOIL OIL DERIVATIVES.
NO993549L (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO980316D0 (en) Process for the preparation of N-vinylcarprolactam polymerisates
NO993948D0 (en) Use of aryl-cyclohexylamine derivatives against CNS disorders
SE9403186D0 (en) Prostaglandin derivatives devoid of side effects for the treatment of glaucoma
NO972129D0 (en) Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives
FI951047A0 (en) Process for the preparation of indole derivatives
FI935609A (en) Asymmetric hydrogenation of dihydrofuroimidazole derivatives
EE200300194A (en) Use of substituted benzopyran derivatives for the treatment of inflammation
NO974458D0 (en) Preparation of cis-4-O-protected-2-cyclopentenol derivatives